Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

BillionToOne, Inc.

BLLNNASDAQ
Healthcare
Medical - Diagnostics & Research
$76.38
$-14.05(-15.53%)
U.S. Market is Open • 12:42

BillionToOne, Inc. Fundamental Analysis

BillionToOne, Inc. (BLLN) shows weak financial fundamentals with a PE ratio of -270.34, profit margin of -5.59%, and ROE of -8.28%. The company generates $0.3B in annual revenue with weak year-over-year growth of 1.13%.

Key Strengths

PEG Ratio-5.11
Current Ratio6.17

Areas of Concern

ROE-8.28%
Operating Margin-2.36%
We analyze BLLN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 31.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
31.4/100

We analyze BLLN's fundamental strength across five key dimensions:

Efficiency Score

Weak

BLLN struggles to generate sufficient returns from assets.

ROA > 10%
-4.34%

Valuation Score

Excellent

BLLN trades at attractive valuation levels.

PE < 25
-270.34
PEG Ratio < 2
-5.11

Growth Score

Moderate

BLLN shows steady but slowing expansion.

Revenue Growth > 5%
1.13%
EPS Growth > 10%
49.73%

Financial Health Score

Excellent

BLLN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.60
Current Ratio > 1
6.17

Profitability Score

Weak

BLLN struggles to sustain strong margins.

ROE > 15%
-827.97%
Net Margin ≥ 15%
-5.59%
Positive Free Cash Flow
No

Key Financial Metrics

Is BLLN Expensive or Cheap?

P/E Ratio

BLLN trades at -270.34 times earnings. This suggests potential undervaluation.

-270.34

PEG Ratio

When adjusting for growth, BLLN's PEG of -5.11 indicates potential undervaluation.

-5.11

Price to Book

The market values BillionToOne, Inc. at 21.35 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

21.35

EV/EBITDA

Enterprise value stands at -2573.36 times EBITDA. This is generally considered low.

-2573.36

How Well Does BLLN Make Money?

Net Profit Margin

For every $100 in sales, BillionToOne, Inc. keeps $-5.59 as profit after all expenses.

-5.59%

Operating Margin

Core operations generate -2.36 in profit for every $100 in revenue, before interest and taxes.

-2.36%

ROE

Management delivers $-8.28 in profit for every $100 of shareholder equity.

-8.28%

ROA

BillionToOne, Inc. generates $-4.34 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.34%

Following the Money - Real Cash Generation

Operating Cash Flow

BillionToOne, Inc. generates limited operating cash flow of $5.51M, signaling weaker underlying cash strength.

$5.51M

Free Cash Flow

BillionToOne, Inc. generates weak or negative free cash flow of $-4.16M, restricting financial flexibility.

$-4.16M

FCF Per Share

Each share generates $-0.09 in free cash annually.

$-0.09

FCF Yield

BLLN converts -0.10% of its market value into free cash.

-0.10%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-270.34

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-5.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

21.35

vs 25 benchmark

P/S Ratio

Price to sales ratio

15.46

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.60

vs 25 benchmark

Current Ratio

Current assets to current liabilities

6.17

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.08

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

-0.02

vs 25 benchmark

How BLLN Stacks Against Its Sector Peers

MetricBLLN ValueSector AveragePerformance
P/E Ratio-270.3429.43 Better (Cheaper)
ROE-8.28%800.00% Weak
Net Margin-5.59%-20145.00% (disorted) Weak
Debt/Equity0.600.30 Weak (High Leverage)
Current Ratio6.174.64 Strong Liquidity
ROA-4.34%-17936.00% (disorted) Weak

BLLN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews BillionToOne, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

112.72%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

49.72%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

22.91%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ